- Home
- DATS vs BGLC Comparison
DATS vs BGLC Comparison
Compare DATS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- BGLC
- Stock Information
- Founded
- DATS 2014
- BGLC 2017
- Country
- DATS United States
- BGLC Malaysia
- Employees
- DATS N/A
- BGLC N/A
- Industry
- DATS Computer Software: Prepackaged Software
- BGLC Medical Specialities
- Sector
- DATS Technology
- BGLC Health Care
- Exchange
- DATS Nasdaq
- BGLC Nasdaq
- Market Cap
- DATS 5.2M
- BGLC 5.8M
- IPO Year
- DATS 2021
- BGLC N/A
- Fundamental
- Price
- DATS $5.04
- BGLC $0.34
- Analyst Decision
- DATS
- BGLC
- Analyst Count
- DATS 0
- BGLC 0
- Target Price
- DATS N/A
- BGLC N/A
- AVG Volume (30 Days)
- DATS 25.0M
- BGLC 10.9M
- Earning Date
- DATS 11-14-2024
- BGLC 02-20-2025
- Dividend Yield
- DATS N/A
- BGLC N/A
- EPS Growth
- DATS N/A
- BGLC N/A
- EPS
- DATS N/A
- BGLC N/A
- Revenue
- DATS $515.00
- BGLC $9,259,858.00
- Revenue This Year
- DATS N/A
- BGLC N/A
- Revenue Next Year
- DATS N/A
- BGLC N/A
- P/E Ratio
- DATS N/A
- BGLC N/A
- Revenue Growth
- DATS N/A
- BGLC N/A
- 52 Week Low
- DATS $1.01
- BGLC $0.21
- 52 Week High
- DATS $9.34
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- DATS 56.03
- BGLC 54.32
- Support Level
- DATS $4.30
- BGLC $0.33
- Resistance Level
- DATS $6.02
- BGLC $0.41
- Average True Range (ATR)
- DATS 1.67
- BGLC 0.11
- MACD
- DATS 0.07
- BGLC 0.00
- Stochastic Oscillator
- DATS 42.21
- BGLC 13.21
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.